Publications by authors named "Ernie Anand"

Claim this Profile
C
Clinical outcomes with olanzapine long-acting injection: impact of the 3-hour observation period on patient satisfaction and well-being.
Ernie Anand, Lovisa Berggren, John Landry, Ágoston Tóth, Holland C Detke

Neuropsychiatr Dis Treat· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Research.
Victoria A Reed, Jan K Buitelaar, Ernie Anand, Kathleen Ann Day, Tamás Treuer

CNS Drugs· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attention-deficit/hyperactivity disorder Under Treatment Outcomes Research (AUTOR): a European observational study in pediatric subjects.
Virginia Haynes, Pedro Lopez-Romero, Ernie Anand

Atten Defic Hyperact Disord· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation.
Ernie Anand, Lovisa Berggren, Claudia Deix, Ágoston Tóth, David P McDonnell

Neuropsychiatr Dis Treat· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olanzapine long-acting injection: a review of first experiences of post-injection delirium/sedation syndrome in routine clinical practice.
Chris J Bushe, Deborah Falk, Ernie Anand, Marta Casillas, Elena Perrin

BMC Psychiatry· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical research.
Nicola C Savill, Jan K Buitelaar, Ernie Anand, Kathleen Ann Day, Tamás Treuer

CNS Drugs· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature.
Ylva Ginsberg, Javier Quintero, Ernie Anand, Marta Casillas, Himanshu P Upadhyaya

Prim Care Companion CNS Disord· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors of improvement in health-related quality of life in atomoxetine-treated children and adolescents with attention-deficit/hyperactivity disorder, based on a pooled analysis.
Alonso Montoya, Deborah Quail, Ernie Anand, Esther Cardo, José A Alda

Atten Defic Hyperact Disord· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses.
Antonio Ciudad, Ernie Anand, Lovisa Berggren, Marta Casillas, Alexander Schacht

Neuropsychiatr Dis Treat· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast vs. slow switching from stimulants to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder.
Esther Cardo, Vibeke Porsdal, Deborah Quail, Joaquin Fuentes, Christopher Steer, Ernie Anand

J Child Adolesc Psychopharmacol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis